London
· Delayed Price · Currency is GBP · Price in GBX GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of GBP 59.05 billion. The enterprise value is 72.49 billion.
| Market Cap | 59.05B |
| Enterprise Value | 72.49B |
Important Dates
The next estimated earnings date is Monday, July 28, 2025.
| Earnings Date | Jul 28, 2025 |
| Ex-Dividend Date | May 15, 2025 |
Share Statistics
GSK plc has 4.06 billion shares outstanding. The number of shares has increased by 0.73% in one year.
| Current Share Class | 4.06B |
| Shares Outstanding | 4.06B |
| Shares Change (YoY) | +0.73% |
| Shares Change (QoQ) | -0.19% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 88.94% |
| Float | 3.92B |
Valuation Ratios
The trailing PE ratio is 19.13 and the forward PE ratio is 8.58. GSK plc's PEG ratio is 1.31.
| PE Ratio | 19.13 |
| Forward PE | 8.58 |
| PS Ratio | 1.87 |
| PB Ratio | 4.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.31 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.18, with an EV/FCF ratio of 13.47.
| EV / Earnings | 22.99 |
| EV / Sales | 2.30 |
| EV / EBITDA | 8.18 |
| EV / EBIT | 11.60 |
| EV / FCF | 13.47 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 1.35.
| Current Ratio | 0.87 |
| Quick Ratio | 0.58 |
| Debt / Equity | 1.35 |
| Debt / EBITDA | 2.08 |
| Debt / FCF | 3.42 |
| Interest Coverage | 10.32 |
Financial Efficiency
Return on equity (ROE) is 27.10% and return on invested capital (ROIC) is 12.39%.
| Return on Equity (ROE) | 27.10% |
| Return on Assets (ROA) | 6.55% |
| Return on Invested Capital (ROIC) | 12.39% |
| Return on Capital Employed (ROCE) | 15.68% |
| Revenue Per Employee | 459,412 |
| Profits Per Employee | 45,943 |
| Employee Count | 68,629 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.51 |
Taxes
In the past 12 months, GSK plc has paid 754.00 million in taxes.
| Income Tax | 754.00M |
| Effective Tax Rate | 14.39% |
Stock Price Statistics
The stock price has decreased by -16.32% in the last 52 weeks. The beta is 0.27, so GSK plc's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -16.32% |
| 50-Day Moving Average | 1,415.19 |
| 200-Day Moving Average | 1,441.22 |
| Relative Strength Index (RSI) | 60.19 |
| Average Volume (20 Days) | 8,019,044 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of GBP 31.53 billion and earned 3.15 billion in profits. Earnings per share was 0.76.
| Revenue | 31.53B |
| Gross Profit | 22.68B |
| Operating Income | 6.25B |
| Pretax Income | 4.23B |
| Net Income | 3.15B |
| EBITDA | 8.65B |
| EBIT | 6.25B |
| Earnings Per Share (EPS) | 0.76 |
Balance Sheet
The company has 4.49 billion in cash and 18.43 billion in debt, giving a net cash position of -13.95 billion or -3.44 per share.
| Cash & Cash Equivalents | 4.49B |
| Total Debt | 18.43B |
| Net Cash | -13.95B |
| Net Cash Per Share | -3.44 |
| Equity (Book Value) | 13.65B |
| Book Value Per Share | 3.47 |
| Working Capital | -2.75B |
Cash Flow
In the last 12 months, operating cash flow was 6.74 billion and capital expenditures -1.36 billion, giving a free cash flow of 5.38 billion.
| Operating Cash Flow | 6.74B |
| Capital Expenditures | -1.36B |
| Free Cash Flow | 5.38B |
| FCF Per Share | 1.33 |
Margins
Gross margin is 71.92%, with operating and profit margins of 19.83% and 10.00%.
| Gross Margin | 71.92% |
| Operating Margin | 19.83% |
| Pretax Margin | 13.42% |
| Profit Margin | 10.00% |
| EBITDA Margin | 27.45% |
| EBIT Margin | 19.83% |
| FCF Margin | 17.07% |
Dividends & Yields
This stock pays an annual dividend of 0.61, which amounts to a dividend yield of 4.22%.
| Dividend Per Share | 0.61 |
| Dividend Yield | 4.22% |
| Dividend Growth (YoY) | 5.08% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 78.91% |
| Buyback Yield | -0.73% |
| Shareholder Yield | 3.48% |
| Earnings Yield | 5.34% |
| FCF Yield | 9.11% |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
| Last Split Date | Jul 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 1.78 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.78 |
| Piotroski F-Score | 7 |